Prevalence of multiple native valvular heart disease in TAVR patients: a multicenter study assessing the impact of staged transcatheter edge-to-edge repair
Event: ESC Congress 2024
Topic: Intervention
Session: The 50 shades of TAVI
The CT-derived fat-free muscle fraction is associated with inflammation and predicts outcome in patients with aortic stenosis undergoing TAVR
Event: ESC Congress 2024
Topic: Imaging
Session: Synergies of multimodality imaging in TAVI
Cholesterol crystal dissolution rate of serum is associated with iliofemoral calcification and predicts outcomes in patients undergoing TAVR
Event: ESC Congress 2023
Topic: Intervention
Session: Advances and remaining challenges in percutaneous valve intervention
Myocardial infarction with ST-segment elevation caused by caseous mitral annular calcification
Event: ESC Congress 2023
Topic: Clinical
Session: Coronary disorders
Hemodynamic effects and challenges of combined use of extracorporeal membrane oxygenation and ventricular support for refractory cardiogenic shock: a case report
Event: ESC Congress 2023
Topic: Clinical
Session: Acute cardiac care (1)
Safety and efficacy of protamine administration for prevention of bleeding complications in patients with recent PCI undergoing TAVR
Event: ESC Congress 2023
Topic: Intervention
Session: Walking the line between bleeding and thrombosis in valvular heart disease
The association of CT-assessed fat-free muscle fraction with frailty and malnutrition and the predictive value of their combination in patients undergoing TAVR
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Predictors of outcomes in transcatheter aortic valve implantation
Incidence and management of multiple native valvular heart disease in patients undergoing TAVR: Impact of staged valvular interventions on outcomes
Event: ESC Congress 2023
Topic: Intervention
Session: Predictors of outcomes in transcatheter aortic valve implantation
Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR - a multicentre experience
Event: ESC Congress 2022
Topic: Intervention
Session: Challenges in transcatheter aortic valve intervention
Novel assay for quantifying the cholesterol crystal dissolution capacity of serum predicts outcomes in patients with severe aortic stenosis undergoing TAVR
Event: ESC Congress 2022
Topic: Aortic Valve Stenosis
Session: Pathophysiology and disease progression in aortic stenosis
